INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
80 hedge funds and large institutions have $125M invested in Infinity Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-14
Holders Change %
-14.89%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
23
Reduced
30
Closed
21
Calls
$536K
Puts
$368K
Net Calls
+$168K
Net Calls Change
+$1.19M
Top Buyers
| 1 |
BlackRock
New York
|
+$9.43M |
| 2 |
DM
Deerfield Management
New York
|
+$6.36M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.3M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.65M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.59M |
Top Sellers
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.13M |
| 2 |
Millennium Management
New York
|
-$1.78M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.61M |
| 4 |
Renaissance Technologies
New York
|
-$842K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$789K |
